Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.

MLA

Mattos, Waldo L. L. D., et al. “Phase 2, Double-Blind, Placebo-Controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.” American Journal of Respiratory and Critical Care Medicine, vol. 210, no. 4, Aug. 2024, pp. 435–43. EBSCOhost, https://doi.org/10.1164/rccm.202310-1907OC.

APA

Mattos, W. L. L. D., Khalil, N., Spencer, L. G., Bonella, F., Folz, R. J., Rolf, J. D., Mogulkoc, N., Lancaster, L. H., Jenkins, R. G., Lynch, D. A., Noble, P. W., Maher, T. M., Cottin, V., Senger, S., Horan, G. S., Greenberg, S., & Popmihajlov, Z. (2024). Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 210(4), 435–443. https://doi.org/10.1164/rccm.202310-1907OC

Chicago

Mattos, Waldo L L D, Nasreen Khalil, Lisa G Spencer, Francesco Bonella, Rodney J Folz, J Douglass Rolf, Nesrin Mogulkoc, et al. 2024. “Phase 2, Double-Blind, Placebo-Controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.” American Journal of Respiratory and Critical Care Medicine 210 (4): 435–43. doi:10.1164/rccm.202310-1907OC.